Diagnostic Radiopharmaceuticals and Contrast Media Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Diagnostic Radiopharmaceuticals and Contrast Media Market size is expected to grow at an annual average of 4% during 2021-2027. Diagnostic radiopharmaceuticals are molecules containing drugs with radioactive isotopes that target specific tissues/organs, and are intended for diagnosis and treatment of diseases such as cancer, cardiovascular disease, and hyperthyroidism. Radiopharmaceuticals are used extensively in a technique called molecular imaging as biomarkers for specific molecular procedures that determine the onset and/or growth of disease.

The following segmentation are covered in this report:

By Application

• Radiology
• Interventional Radiology
• Interventional Cardiology
• Others

 By Product Type

• Technetium (Tc-99m)
• Thallium (Tl-201)
• Gallium (Ga-67)
• Iodine (I-123)
• Rhenium (Re-186)
• Yttrium (Y-90)
• Fluorine-18 (18F-FDG)
• Rubidium (Rb-82)
• Others

 Company Profile

• NTP Radioisotopes SOC Ltd.
• Nordion, Inc.
• Lantheus Medical Imaging, Inc.
• IBA Group a.s.
• Medtronic
• Eckert & Ziegler
• Advanced Accelerator Applications
• Medtron AG
• Bayer
• Mallinckrodt Pharmaceuticals
• Bracco Imaging S.p.A.

Scope of the report

The research study analyses the Diagnostic Radiopharmaceuticals and Contrast Media Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Diagnostic Radiopharmaceuticals and Contrast Media Market Report

• What was the Diagnostic Radiopharmaceuticals and Contrast Media Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Diagnostic Radiopharmaceuticals and Contrast Media Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.